Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Cheng Hsu

Showing results (61-70 of 384) with videos related to

Pageof 39
Sort By:
Scientific Reports|June 26, 2020
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary diseaseFu-Shun Yen, James Cheng-Chung Wei, Yu-Cih Yang, et al.
Frontiers in Endocrinology|December 6, 2021
The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort StudyFu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, et al.
Frontiers in Medicine|March 17, 2020
Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With GoutFu-Shun Yen, Chih-Cheng Hsu, Hsin-Lun Li, et al.
Medicine|March 3, 2021
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort studyFu-Shun Yen, Chih-Cheng Hsu, Yuan-Chih Su, et al.
BMC Public Health|January 25, 2013
Joint predictability of health related quality of life and leisure time physical activity on mortality risk in people with diabetesChia-Lin Li, Hsing-Yi Chang, Chih-Cheng Hsu, et al.
Diabetes Research and Clinical Practice|June 25, 2021
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Jia-Sin Liu, et al.
Frontiers in Pharmacology|September 8, 2022
Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary diseaseFu-Shun Yen, James Cheng-Chung Wei, Lu-Ting Chiu, et al.
Journal of Translational Medicine|January 4, 2022
Diabetes, hypertension, and cardiovascular disease developmentFu-Shun Yen, James Cheng-Chung Wei, Lu-Ting Chiu, et al.
Frontiers in Medicine|December 27, 2021
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary DiseaseFu-Shun Yen, James Cheng-Chung Wei, Yu-Cih Yang, et al.
Cardiovascular Diabetology|May 10, 2023
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort studyFu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, et al.
Pageof 39

Showing results (61-70 of 384) with videos related to

Sort By:
Pageof 39
Scientific Reports|June 26, 2020
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary diseaseFu-Shun Yen, James Cheng-Chung Wei, Yu-Cih Yang, et al.
Frontiers in Endocrinology|December 6, 2021
The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort StudyFu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, et al.
Frontiers in Medicine|March 17, 2020
Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With GoutFu-Shun Yen, Chih-Cheng Hsu, Hsin-Lun Li, et al.
Medicine|March 3, 2021
Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort studyFu-Shun Yen, Chih-Cheng Hsu, Yuan-Chih Su, et al.
BMC Public Health|January 25, 2013
Joint predictability of health related quality of life and leisure time physical activity on mortality risk in people with diabetesChia-Lin Li, Hsing-Yi Chang, Chih-Cheng Hsu, et al.
Diabetes Research and Clinical Practice|June 25, 2021
Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Jia-Sin Liu, et al.
Frontiers in Pharmacology|September 8, 2022
Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary diseaseFu-Shun Yen, James Cheng-Chung Wei, Lu-Ting Chiu, et al.
Journal of Translational Medicine|January 4, 2022
Diabetes, hypertension, and cardiovascular disease developmentFu-Shun Yen, James Cheng-Chung Wei, Lu-Ting Chiu, et al.
Frontiers in Medicine|December 27, 2021
Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary DiseaseFu-Shun Yen, James Cheng-Chung Wei, Yu-Cih Yang, et al.
Cardiovascular Diabetology|May 10, 2023
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort studyFu-Shun Yen, James Cheng-Chung Wei, Ying-Hsiu Shih, et al.
Pageof 39